Skip to main content

Advertisement

SpringerLink
Log in

Die rolle der milz in der tumorchirurgie

Role of the spleen in tumor surgery

  • Published:
Langenbecks Archiv für Chirurgie Aims and scope Submit manuscript

Summary

Tumorgenesis and tumor growth are connected with the immune system. Therefore the role of the spleen respectively splenectomy have gained increasing influence. The existing experimental and clinical results are discussed with the help of a general review of the literature. A manipulation of the immune system by splenectomy seems possible. A common pathomechanism has not yet been found. But experimental investigations are transferrable to human beings only under special conditions.

Zusammenfassung

Tumorgenese und -progredienz stehen in engem Zusammenhang mit dem Immunsystem. zunehmend werden die Rolle der Milz beziehungsweise der Splenektomie diskutiert. Anhand einer Literaturübersicht werden die bisher vorliegenden experimentellen und klinischen Ergebnisse dargelegt. Danach ist eine Beeinflussung des Immunsystems durch Splenektomie möglich. Ein allgemein gültiger Pathomechanismus ist aber noch nicht gefunden. Experimentelle Ergebnisse sind allerdings nur bedingt auf den Menschen übertragbar.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Literatur

  1. Ali SA, Hawrylowitz CM, Peel J, Griffith C, Ress RC (1983) Human spleen cells mediating natural killing: altered natural cytotoxicity of spleen effector cells from patients with carcinoma. J Cancer Res Clin Oncol 106:202–209

    Google Scholar 

  2. Akiyoshi T, Koba F, Arinaga S, Wada T, Tsuji H (1988) Cell-mediated cytotoxic activity of spleen cells from patients with gastric carcinoma. Jpn J Surg 18:164–171

    Google Scholar 

  3. Chalmers PJ, Matthews N, Nairn RC (1976) Characterization of serum factors modulating splenic cytotoxicity in a syngeneic rat tumor system. Br J Cancer 34:645–650

    Google Scholar 

  4. Chang RW, Turk JL (1977) Increasing resistance in splenectomized mice to a methylcholantrene-induced tumor. Br J Cancer 35:768–776

    Google Scholar 

  5. Davis CJ, Ilstrup DM, Pemberton JH (1988) Influence of splenectomy on survival rate of patients with colorectal cancer. Am J Surg 155:173–179

    Google Scholar 

  6. Dawson AA, Jones PF, King DJ (1987) Splenectomy in the management of haematological disease. Br J Surg 74:353–357

    Google Scholar 

  7. Deppe G, Zbella EA, Skogerson K, Dumitru I (1983) The rare indication for splenectomy as part of cytoreductive surgery in ovarian cancer. Gynecol Oncol 16:282–287

    Google Scholar 

  8. Dürig M, Harder F (1986) Auswirkungen der Splenektomie. Chirurg 57:189–193

    Google Scholar 

  9. Elliot L, Brooks W, Roszman T (1987) Role of interleukin-2 (IL-2) and IL-2 receptor expression in the proliferative defect observed in mitogen-stimulated lymphocytes from patients with gliomas. J Natl Cancer Inst 78:919–922

    Google Scholar 

  10. 10.Falk S, Seipelt G, Müller H, Stutte HJ (1989) Immunhistochemical assessment of splenic lymphocyte and macrophage subpopulations in patients with gastric cancer. Cancer 64:1646–1651

    Google Scholar 

  11. Ferrer JF (1968) Role of the spleen in passive immunological enhancement. Transplantation 6:315

    Google Scholar 

  12. Ferrer JF, Mihich E (1968) Effect of splenectomy on the regression of transplantable tumors. Cancer Res 28:1116–1120

    Google Scholar 

  13. Ferrer JF (1968) Enhancement of the growth of sarcoma 180 in splenectomized and sham-operated AKR mice. Transplantation 6:160–166

    Google Scholar 

  14. Glaser M, Bonnard GD, Herbermann RB (1976) In vitro generation of secondary cell-mediated cytotoxic response against a syngeneic Gross-virus-induced lymphoma in rats. J Immunol 116:430–436

    Google Scholar 

  15. Hoon DSB, Bowker RJ, Cochran AJ (1987) Suppressor cell activity in melanoma-draining lymph nodes. Cancer Res 47:1529–1533

    Google Scholar 

  16. Hull CC, Galloway P, Gordon N, Gerson SL, Hawkins N, Stellato TA (1988) Splenectomy and the induction of murine colon cancer. Arch Surg 123:462–464

    Google Scholar 

  17. Ishibashi T, Yamada H, Harada S, Harada Y, Takamoto M, Sugiyama K (1978) Inhibition and promotion of tumor growth by BCG: evidence for stimulation of Immoral enhancing factors BCG. Int J Cancer 21:67–71

    Google Scholar 

  18. Kanayama H, Hamazoe R, Osaki Y, Shimizu N, Maeta M, Koga S (1985) Immunosuppressive factor from the spleen in gastric cancer patients. Cancer 56:1963–1966

    Google Scholar 

  19. 19.Keller HW, Müller JM, Brenner U, Walter M (1984) Lebensbedrohliche Infektionen nach Splenektomie — das “Overwhelming-post-splenectomy-infection” -Syndrom. Leber Magen Darm 14:18–26

    Google Scholar 

  20. Koga S, Kaibara N, Kimura O, Nishido H, Kishimoto Y (1981) Prognostic significance of combined splenectomy or pancreaticosplenectomy in total and maximal gastrectomy for gastric cancer. Am J Surg 142:546–550

    Google Scholar 

  21. Kunisada K, Hashimoto M, Nakanara H, Arima T, Hayashi S, Okada T, Tanaka T, Yumura M, Takeuchi Y (1975) Effect of immunotherapy combined with splenectomy on growth of tumor and immune response of host meeting. Nippon Gan Gakkai 34th Annual Meeting 10.75:71–74

    Google Scholar 

  22. Kurz A, Saß W, Seifert J, Hamelmann H (1988) Verlauf einer septischen Peritonitis bei Patienten mit und ohne Milz. Med Klin 83:354–357

    Google Scholar 

  23. Ligo M, Nakajiama Y, Nishikata K, Hoshi A (1989) Effects of interleukin-2 and interferon-alpha A/D treatment on lymphocytes from tumor-bearing mice. Br J Cancer 59:883–888

    Google Scholar 

  24. Likhite VV (1975) Opsonin and leukophilic — globulin in chronically splenectomized rats with and without heterotopic autotransplanted splenic tissue. Nature 253: 742–744

    Google Scholar 

  25. Maccubbin DL, Mace KF, Ehrke MJ, Mihich E (1989) Modification of host antitumor defense mechanisms in mice by progressively growing tumor. Cancer Res 49:4216–4224

    Google Scholar 

  26. Meyer JD, Argyris BF, Meyer JA (1980) Splenectomy, suppressor cell activity, and survival in tumor bearing rats. J Surg Res 29: 527–532

    Google Scholar 

  27. Miescher S, Whiteside TL, Carrel S, von Flieder V (1986) Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumor: effect of tumor cells and their supernatants on proliferative responses of lymphocytes. J Immunol 136:1899–1907

    Google Scholar 

  28. Miwa H, Orita K (1983) Splenectomy combined with gastrectomy and immunotherapy for advanced gastric cancer. Acta Med Okayama 37:251–258

    Google Scholar 

  29. Moretta A, Colombatti M, Chapuis B (1981) Human spleen as a source of T cell growth factor. Clin Exp Immunol 44: 262–269

    Google Scholar 

  30. Morikawa K, Walker SM, Nakajiama M, Jessup JM, Fidler IJ (1988) Influence of organ invironment of the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res 48:6863–6871

    Google Scholar 

  31. Müller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H (1990) Surgical therapy of oesophageal carcinoma. Br J Surg 77:845–857

    Google Scholar 

  32. Neel HB, Ritts RE (1977) Transfer of tumor-specific immunity with syngeneic spleen cell's and serum from mice that have large tumors and metastases. Cancer 40:1643–1649

    Google Scholar 

  33. Nielsen JL, Ellgaard J (1982) Influence of residual splenic tissue on autoantibodies in splenectomized patients. Scand J Haematol 28:273–277

    Google Scholar 

  34. Nordlund JJ, Gershon RK (1975) Splenic regulation of the clinical appearance of small tumors. J Immunol 114:1486–1490

    Google Scholar 

  35. Oisgold-Daga S, Jasnis MA, Klein S, deBonaparte YP (1982) Immune reactivity of spleen cells in advanced stages of tumor growth. Biomedicine 36:319–323

    Google Scholar 

  36. Okada T, Matsuo Y, Ohkubo A, Fukuda H, Arima T, Tanaka N, Kaneda S, Kokumai Y, Orita K, Tanaka S (1974) Effect of splenectomy on tumor growth and MIF activity (meeting abstract) GANN 71:308

    Google Scholar 

  37. Oku H, Hirai Y, Hamazoe R, Kanayama H, Maeta M, Koga S (1978) Immunological role of splenic lymphocytes to growth of Ehrlich cancer in mice. (Meeting abstract) Jpn Cancer Assoc 283:145

    Google Scholar 

  38. Orita K, Konaga E, Okada T, Kunisada K, Yumura M, Tanaka S (1977) Effect of splenectomy in tumor-bearing mice and gastric cancer patients. Gann 68:731–736

    Google Scholar 

  39. Pate JW, Peters TG, Andrews CR (1985) Postsplenectomy complications. Am Surg 51:437–441

    Google Scholar 

  40. Pollack SB, Lee MY, Cohen E, Lottsfeld JL, Rosse C (1989) Modulation of murine natural killer cells by a granulocytosisinducing tumor. Cancer Res 49:174–178

    Google Scholar 

  41. Robinette CD, Faumeni J (1977) Splenectomy and subsequent mortality in veterans of the 1939–45 war. Lancet 11:127–129

    Google Scholar 

  42. Rumi L, Pasqualini CD, Rabasa S (1971) Growth of sarcoma 180 in splenectomized mice bearing diffusion chambers containing spleen of tumor cells. Eur J Cancer 7:551–555

    Google Scholar 

  43. Sato N, Michaelides MC, Wallack MK (1983) Effect of splenectomy on the growth of murine colon tumors. J Surg Oncol 22:73–76

    Google Scholar 

  44. Scherbakov Y (1973) The effect of splenectomy on the growth of sarkoma in syngeneic inoculation of the tumor in mice. Biull Eksp Biol Med 75:79–81

    Google Scholar 

  45. Schikawa T, Shatney CH (1983) Septic sequelae after splenectomy for trauma in adults. Am J Surg 145:667–673

    Google Scholar 

  46. Shatney CH (1987) Complications of splenectomy. Acta Anaesthesiol Belg 38:333–339

    Google Scholar 

  47. Slavin S, Morecki S, Weiss L (1980) The role of the spleen in tumor growth kinetics of the murine B cell leukemia (BCL2). J Immunol 124:586–589

    Google Scholar 

  48. Subiza JL, Vinuela JE, Rodriguez R, Figueredo MA, delaConcha EG (1989) Development of splenic natural suppressor (NS) cells in ehrlich tumor bearing mice. Int J Cancer 44:307–314

    Google Scholar 

  49. Sugimachi K, Kodoma Y, Kuma Shiro R, Kanematsu T, Noda S, Inokuchi K (1980) Critical evaluation of prophylactic splenectomy in total gastrectomy for the stomach cancer. Gann 71:704–709

    Google Scholar 

  50. Syränen UJ (1980) Spleen white pulp morphology in the evaluation of the immunological reactivity of patients died with widespread gastric carcinoma. Arch Geschwulstforsch 50: 647–656

    Google Scholar 

  51. Veith FJ, Luck RJ, Murray JE (1965) The effects of splenectomy on immunsuppressive regimes in dog and man. Surg Gynecol Obstet 8:299–308

    Google Scholar 

  52. Wallenberg von H, Mainusch P, Meyer J, Hammer C (1979) Der Einfluß der Milz auf das Wachstum von Tumoren in Mäuselinien mit unterschiedlichen Milzgröße. Langenbecks Arch Chir [Suppl] Chir Forum S 169–173

    Google Scholar 

  53. Weiss L (1983) The red pulp of the spleen: structural basis of blood flow. Clin Hematol 12:375–381

    Google Scholar 

  54. Werbin N, Lodba K (1982) Malign effects of splenectomy — the place of conservative treatment. Postgrad Med J 58:65–69

    Google Scholar 

  55. Whitney RB, Levy J, Smith AG (1974) Influence of tumor size and surgical resection on cell-mediated immunity in mice. J Natl Cancer Inst 53:111–116

    Google Scholar 

  56. Wolters U, Keller HW, Miller JM, Pichlmaier H (1991) Die Auswirkungen der akzidentellen Splenektomie auf das Langzeitergebnis in der colorectalen Tumorchirurgie. Chirurgie 62:47–50

    Google Scholar 

  57. Yacov R, Gorelik E, Feldmann M, Segal S (1982) Effect of splenectomy on the progression of postoperative pulmonary metastases of the 3LL tumor. Eur J Cancer Clin Oncol 18:391–397

    Google Scholar 

  58. Yamagishi H, Pellis NR; Kahan BD (1980) Effect of splenectomy upon tumor growth: characterization of splenic tumor-enhancing cells in vivo. Surgery 87:655–661

    Google Scholar 

  59. Yigong GE, Gao H, Kong X (1989) Changes of peripheral T-cell subsets in asplenic W256 tumor-bearing rats. J Surg Oncol 42:60–68

    Google Scholar 

  60. Yoshino K, Haryama U (1983) Bedeutung der Splenektomie für die Lymphknotenausräumung beim Magencarcinom. Aktuel Chir 18:81–84

    Google Scholar 

  61. Yumura M, Hayashi S, Okada T, Yamamoto I, Fukuda H, Miwa H, Mannami T, Konaga E, Kokumai Y, Orita K, Tanaka S (1975) Immunotherapy. II. Cancer immunotherapy combined with splenectomy. Jpn J Surg Soc 76:1076–1078

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Chirurgische Universitätsklinik, Joseph-Stelzmann-Straße 9, W-5000, Köln 41, BRD

    U. Wolters, H. W. Keller & H. Pichlmaier

Authors
  1. U. Wolters
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. W. Keller
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Pichlmaier
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wolters, U., Keller, H.W. & Pichlmaier, H. Die rolle der milz in der tumorchirurgie. Langenbecks Arch Chir 376, 280–285 (1991). https://doi.org/10.1007/BF00188268

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00188268

Key words Spleen

Search

Navigation